 The FTC is suing the three largest pharmacy benefit managers over the cost of insulin and other drugs. This lawsuit is expected to target those so-called middlemen that pushed patients to more expensive insulin. Lawmakers and federal regulators accused drug makers of inflating the price of the drug. Politico reports United Health Group, CVS, and Cigna are all expected to face lawsuits. Now, they represent about 80% of prescriptions here in the U.S.